Community Involvment <<  1  2  3  4  5  6  7  8  >>
ISB RESEARCHERS ABOUT TOWN
     ISB researchers are steppin' out to make sure Seattleites are aware of the work being conducted at a young, globally influential non-profit research institute right in their own backyard.
     "We are probably better known around the world for our scientific leadership than we are in our home town," said Larry Herron, ISB's vice president for Development. "It's time we took the Institute off the 'best kept secrets' list and let people know they have the opportunity to support some of the most advanced healthcare research in the world."
     From January through June ISB's co-founders and senior research scientists have presented at Science on Tap, Emerald City Rotary, Skyline Rotary, Darwin Day at Pacific Science Center, Seattle's Town Hall, Queen Anne Rotary, University Sunrise Rotary, Women's University Club, Seraph Capital Forum and Bellevue Rotary.
     Presentations generally include a brief introduction to ISB and its mission, the latest work in that scientist's area of expertise and an explanation of how that research could improve the diagnosis and treatment of diseases such as cancer, heart disease, diabetes, Alzheimer's and many more.
     If you would like an ISB scientist to discuss how the Institute is making breakthrough discoveries in predictive and preventive medicine, please contact Renée Duprel at (206) 732-1398 or rduprel@systemsbiology.org.     Alan Aderem, PhD, ISB director and co-founder, at Seattle's Town Hall and Dan Martin, MD, ISB assistant professor, at Emerald City Rotary.
ISB AND SWEDISH NEUROSCIENCE INSTITUTE KICK OFF UNIQUE BRAIN TUMOR PARTNERSHIP
     Lee Hood, MD, PhD, ISB president and co-founder, and Greg Foltz, MD, neurosurgeon and head of the Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute (SNI), recently debuted their fund-raising collaboration to attack brain cancer at the home of campaign donors Dave and Sandy Sabey.
     A group of approximately 40 community leaders and philanthropists heard how the collaboration will address glioblastoma multiforme, one of the deadliest cancers known to mankind. Today only 3 percent of people diagnosed with this form of cancer will survive more than five years.
     SNI and ISB are working together to provide the most advanced treatments
available today and the hope of a cure tomorrow. And while patients in the Northwest will benefit most directly from this campaign, the research, diagnostic tools and treatments developed will benefit glioblastoma patients and families around the globe.
     To learn more about this groundbreaking partnership, please contact Shawn Swift at (206)732-1232 or sswift@systemsbiology.org.

PAGE 3 <<  1  2  3  4  5  6  7  8  >>